NEKTAR THERAPEUTICS Insider Trading for February 2017
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in NEKTAR THERAPEUTICS.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in NEKTAR THERAPEUTICS for February 2017.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb 23 2017 | NKTR | NEKTAR THERAPEUTIC ... | Lingnau Lutz | Director | Option Exercise | M | 5.14 | 30,000 | 154,200 | 0 | |
| Feb 23 2017 | NKTR | NEKTAR THERAPEUTIC ... | Lingnau Lutz | Director | Sell | S | 13.08 | 30,000 | 392,400 | 30,450 | 60.5 K to 30.5 K (-49.63 %) |
| Feb 23 2017 | NKTR | NEKTAR THERAPEUTIC ... | Lingnau Lutz | Director | Buy | M | 5.14 | 30,000 | 154,200 | 60,450 | 30.5 K to 60.5 K (+98.52 %) |
| Feb 17 2017 | NKTR | NEKTAR THERAPEUTIC ... | Thomsen Jillian B. | SVP & Chief Account ... | Sell | S | 13.14 | 1,965 | 25,820 | 55,637 | 57.6 K to 55.6 K (-3.41 %) |
| Feb 17 2017 | NKTR | NEKTAR THERAPEUTIC ... | ROBIN HOWARD W | President & CEO | Sell | S | 13.14 | 8,636 | 113,477 | 169,272 | 177.9 K to 169.3 K (-4.85 %) |
| Feb 17 2017 | NKTR | NEKTAR THERAPEUTIC ... | Nicholson John | SVP & Chief Operati ... | Sell | S | 13.14 | 3,237 | 42,534 | 182,089 | 185.3 K to 182.1 K (-1.75 %) |
| Feb 17 2017 | NKTR | NEKTAR THERAPEUTIC ... | Labrucherie Gil M | SVP & Chief Financi ... | Sell | S | 13.14 | 2,359 | 30,997 | 69,270 | 71.6 K to 69.3 K (-3.29 %) |
| Feb 17 2017 | NKTR | NEKTAR THERAPEUTIC ... | Hora Maninder | SVP Pharma Dev & Mf ... | Sell | S | 13.14 | 2,195 | 28,842 | 63,648 | 65.8 K to 63.6 K (-3.33 %) |
| Feb 17 2017 | NKTR | NEKTAR THERAPEUTIC ... | Gergel Ivan P. | SVP & Chief Medical ... | Sell | S | 13.14 | 1,457 | 19,145 | 45,022 | 46.5 K to 45 K (-3.13 %) |
| Feb 17 2017 | NKTR | NEKTAR THERAPEUTIC ... | Doberstein Stephen K | SVP & Chief Scienti ... | Sell | S | 13.14 | 1,261 | 16,570 | 34,504 | 35.8 K to 34.5 K (-3.53 %) |
| Feb 10 2017 | NKTR | NEKTAR THERAPEUTIC ... | Nicholson John | SVP & Chief Operati ... | Option Exercise | M | 4.65 | 45,000 | 209,250 | 0 | |
| Feb 10 2017 | NKTR | NEKTAR THERAPEUTIC ... | Nicholson John | SVP & Chief Operati ... | Buy | M | 4.65 | 45,000 | 209,250 | 185,326 | 140.3 K to 185.3 K (+32.07 %) |
| Feb 10 2017 | NKTR | NEKTAR THERAPEUTIC ... | ROBIN HOWARD W | President & CEO | Option Exercise | M | 4.65 | 87,500 | 406,875 | 0 | |
| Feb 10 2017 | NKTR | NEKTAR THERAPEUTIC ... | ROBIN HOWARD W | President & CEO | Sell | S | 13.04 | 87,500 | 1,141,000 | 177,908 | 265.4 K to 177.9 K (-32.97 %) |
| Feb 10 2017 | NKTR | NEKTAR THERAPEUTIC ... | ROBIN HOWARD W | President & CEO | Buy | M | 4.65 | 87,500 | 406,875 | 265,408 | 177.9 K to 265.4 K (+49.18 %) |
| Feb 06 2017 | NKTR | NEKTAR THERAPEUTIC ... | Nicholson John | SVP & Chief Operati ... | Option Exercise | M | 4.65 | 8,505 | 39,548 | 45,000 | |
| Feb 06 2017 | NKTR | NEKTAR THERAPEUTIC ... | Nicholson John | SVP & Chief Operati ... | Option Exercise | M | 4.65 | 66,495 | 309,202 | 53,505 | |
| Feb 06 2017 | NKTR | NEKTAR THERAPEUTIC ... | Nicholson John | SVP & Chief Operati ... | Sell | S | 12.48 | 8,505 | 106,142 | 140,326 | 148.8 K to 140.3 K (-5.71 %) |
| Feb 06 2017 | NKTR | NEKTAR THERAPEUTIC ... | Nicholson John | SVP & Chief Operati ... | Buy | M | 4.65 | 8,505 | 39,548 | 148,831 | 140.3 K to 148.8 K (+6.06 %) |
| Feb 06 2017 | NKTR | NEKTAR THERAPEUTIC ... | Nicholson John | SVP & Chief Operati ... | Sell | S | 12.38 | 66,495 | 823,208 | 140,326 | 206.8 K to 140.3 K (-32.15 %) |
| Feb 06 2017 | NKTR | NEKTAR THERAPEUTIC ... | Nicholson John | SVP & Chief Operati ... | Buy | M | 4.65 | 66,495 | 309,202 | 206,821 | 140.3 K to 206.8 K (+47.39 %) |